JP2023512823A5 - - Google Patents
Info
- Publication number
- JP2023512823A5 JP2023512823A5 JP2022548109A JP2022548109A JP2023512823A5 JP 2023512823 A5 JP2023512823 A5 JP 2023512823A5 JP 2022548109 A JP2022548109 A JP 2022548109A JP 2022548109 A JP2022548109 A JP 2022548109A JP 2023512823 A5 JP2023512823 A5 JP 2023512823A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- alkoxy
- hydrogen
- hydrocarbyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062970425P | 2020-02-05 | 2020-02-05 | |
| US62/970,425 | 2020-02-05 | ||
| PCT/US2021/016848 WO2021158936A1 (en) | 2020-02-05 | 2021-02-05 | Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023512823A JP2023512823A (ja) | 2023-03-29 |
| JP2023512823A5 true JP2023512823A5 (https=) | 2025-03-21 |
| JP7678595B2 JP7678595B2 (ja) | 2025-05-16 |
Family
ID=77199407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548109A Active JP7678595B2 (ja) | 2020-02-05 | 2021-02-05 | ピロロ［２，３‐ｂ］ピリジン‐３‐カルボキサミド組成物及び聴力損失を改善するための方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4100008B1 (https=) |
| JP (1) | JP7678595B2 (https=) |
| CN (1) | CN115515579B (https=) |
| AU (1) | AU2021215925B2 (https=) |
| CA (1) | CA3170121A1 (https=) |
| ES (1) | ES3025983T3 (https=) |
| MX (1) | MX2022009572A (https=) |
| WO (1) | WO2021158936A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023015156A1 (en) * | 2021-08-02 | 2023-02-09 | Hudspeth A James | Pyrrolopyridine-3- and 4-carboxamide compositions and methods for cellular proliferation |
| WO2024211621A1 (en) * | 2023-04-04 | 2024-10-10 | Children's Hospital Los Angeles | Lats kinase inhibitor to treat retinal degeneration |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2888848B1 (fr) * | 2005-07-22 | 2007-09-28 | Sanofi Aventis Sa | Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
| WO2007067537A1 (en) * | 2005-12-07 | 2007-06-14 | Osi Pharmaceuticals, Inc. | Pyrrolopyridine kinase inhibiting compounds |
| PE20121126A1 (es) * | 2006-12-21 | 2012-08-24 | Plexxikon Inc | Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa |
| TWI667233B (zh) * | 2013-12-19 | 2019-08-01 | 德商拜耳製藥公司 | 新穎吲唑羧醯胺，其製備方法、含彼等之醫藥製劑及其製造醫藥之用途 |
| GB201602854D0 (en) * | 2016-02-18 | 2016-04-06 | Mission Therapeutics Ltd | Novel compounds |
| JOP20190257A1 (ar) | 2017-04-28 | 2019-10-28 | Novartis Ag | مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats |
-
2021
- 2021-02-05 CA CA3170121A patent/CA3170121A1/en active Pending
- 2021-02-05 WO PCT/US2021/016848 patent/WO2021158936A1/en not_active Ceased
- 2021-02-05 AU AU2021215925A patent/AU2021215925B2/en active Active
- 2021-02-05 MX MX2022009572A patent/MX2022009572A/es unknown
- 2021-02-05 CN CN202180019399.6A patent/CN115515579B/zh active Active
- 2021-02-05 ES ES21750999T patent/ES3025983T3/es active Active
- 2021-02-05 JP JP2022548109A patent/JP7678595B2/ja active Active
- 2021-02-05 EP EP21750999.1A patent/EP4100008B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12083118B2 (en) | Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same | |
| ES2871027T3 (es) | Inhibidores potentes de la epóxido hidrolasa soluble | |
| ES2810852T3 (es) | Compuestos y composiciones para inhibir la actividad de shp2 | |
| JP2021534124A5 (https=) | ||
| AU2013262320B2 (en) | High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions | |
| JP5822840B2 (ja) | 眼疾患処置薬 | |
| CA2571347A1 (en) | Piperazine derivatives for the treatment of female sexual disorders | |
| RU2557982C2 (ru) | Композиции и способы ингибирования пути jak | |
| JP2005536475A5 (https=) | ||
| JP2007519649A5 (https=) | ||
| CN107660202B (zh) | 水溶性前药 | |
| JP2005538099A5 (https=) | ||
| JP2017505793A (ja) | ｍＩＤＨ１阻害剤としてのベンズイミダゾール−２−アミン | |
| BR112021006033A2 (pt) | Uso de um inibidor de um transportador da família ent no tratamento de câncer e combinação do mesmo com um antagonista do receptor de adenosina | |
| JP2023512823A5 (https=) | ||
| RU2012147511A (ru) | Применение ингибиторов c-src в комбинации с пиримидиламинобензамидом для лечения лейкоза | |
| CN109069461A (zh) | 与髓源性抑制细胞相关的病症的治疗方法 | |
| JP2004525183A5 (https=) | ||
| PT1948176E (pt) | Diaril ureias para tratar a hipertensão pulmonar | |
| TW202114991A (zh) | 離胺醯氧化酶之二氟鹵烯丙胺碸衍生物抑制劑、製備方法、及其用途 | |
| JP2008543781A5 (https=) | ||
| KR102792934B1 (ko) | 세페타프로스트와 Rho 키나아제 저해제의 조합 의약 | |
| JP4933897B2 (ja) | 眼内移行性促進水性点眼剤 | |
| JP2022519274A5 (https=) | ||
| JP2023550902A5 (https=) |